Experimental infection with Schistosoma mansoni in CCR5-deficient mice is associated with increased disease severity, as CCR5 plays a role in controlling granulomatous inflammation

Infection and Immunity

Volumn 79, Issue 4, 2011, Pages 1741-1749

  Souza, Adriano L S ^a   Souza, Patrícia R S ^a   Pereira, Cíntia A ^a   Fernandes, Adriana ^a   Guabiraba, Rodrigo ^a   Russo, Remo C ^a   Vieira, Leda Q ^a   Correâ Jr , Ary ^a   Teixeira, Mauro M ^a   Negrão Corrêa, Deborah ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 5; RANTES; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EXPERIMENTAL INFECTION; FEMALE; GRANULOMATOUS INFLAMMATION; IMMUNE SYSTEM; LIVER GRANULOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SPLEEN CELL;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GRANULOMA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, CCR5; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

EID: 79953319795     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00502-10     Document Type: Article

References (47)

1. Ajuebor, M. N., et al. 2005. Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells. J. Immunol. 174:8027-8037.
2. Algood, H. M., and J. L. Flynn. 2004. CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J. Immunol. 173:3287-3296.
3. Barcelos, L. S., et al. 2005. Impaired inflammatory angiogenesis, but not leukocyte influx, in mice lacking TNFR1. J. Leukoc. Biol. 78:352-358.
4. Cardona, A. E., et al. 2008. Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood 112:256-263.
5. Carter, C. E., and D. G. Colley. 1978. An electrophoretic analysis of Schistosoma mansoni soluble egg antigen preparation. J. Parasitol. 64:285-290.
6. Cheever, A. W. 1968. Conditions affecting accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. Bull. World Health Organ. 39:328-331.
7. Cheever, A. W., et al. 1987. Variation of hepatic fibrosis and granuloma size among mouse strains infected with Schistosoma mansoni. Am. J. Trop. Med. Hyg. 37:85-97.
8. Chiaramonte, M. G., A. W. Cheever, J. D. Malley, D. D. Donaldson, and T. A. Wynn. 2001. Studies of murine schistosomiasis reveal interleukin-13 block-ade as a treatment for established and progressive liver fibrosis. Hepatology 34:273-282.
9. Chiaramonte, M. G., D. D. Donaldson, A. W. Cheever, and T. A. Wynn. 1999. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 104:777-785.
10. Chiaramonte, M. G., et al. 1999. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J. Immunol. 162:920-930.
11. Dairaghi, D. J., et al. 1998. Macrophage inflammatory protein-1beta induces migration and activation of human thymocytes. Blood 91:2905-2913.
12. de Jesus, A. R., et al. 2004. Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection. Infect. Immun. 72:3391-3397.
13. Deng, H., et al. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
14. Dessein, A., et al. 2004. Interleukin-13 in the skin and interferon-gamma in the liver are key players in immune protection in human schistosomiasis. Immunol. Rev. 201:180-190.
15. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
16. Falcão, P. L., et al. 2002. Plasma concentrations and role of macrophage inflammatory protein-1alpha during chronic Schistosoma mansoni infection in humans. J. Infect. Dis. 186:1696-1700.
17. Fallon, P. G., E. J. Richardson, G. J. McKenzie, and A. N. McKenzie. 2000. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J. Immunol. 164:2585-2591.
18. Fritsch, L., et al. 1998. Production of HIV-1 by human B cells infected in vitro: characterization of an EBV genome-negative B cell line chronically synthesizing a low level of HIV-1 after infection. Virology 244:542-551.
19. Gao, J. L., et al. 1997. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185:1959-1968.
20. Green, A. P., F. Mangan, and J. E. Ormerod. 1980. Induction of cell infiltration and acid hydrolase release into the peritoneal cavity of mice. Inflammation 4:205-213.
21. Huang, Y., et al. 1996. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1240-1243.
22. Jankovic, D., et al. 1999. Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J. Immunol. 163:337-342.
23. Junqueira, L. C., G. Bignolas, and R. R. Brentani. 1979. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem. J. 11:447-455.
24. Kang, S. G., et al. 2007. Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine. Gastroenterology 132:966-981.
25. Kaviratne, M., et al. 2004. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J. Immunol. 173:4020-4029.
26. Khan, I. A., et al. 2006. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog. 2:e49.
27. Kroetz, D. N., and G. S. Deepe, Jr. 2010. CCR5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T cells in fungal infection. J. Immunol. 184:5224-5231.
28. Lim, H. W., J. Lee, P. Hillsamer, and C. H. Kim. 2008. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J. Immunol. 180:122-129.
29. Machado, F. S., et al. 2005. CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi. J. Infect. Dis. 191:627-636.
30. Magalhães, A., et al. 2004. Cytokine profile associated with human chronic schistosomiasis mansoni. Mem. Inst. Oswaldo Cruz 99:21-26.
31. McKenzie, G. J., P. G. Fallon, C. L. Emson, R. K. Grencis, and A. N. McKenzie. 1999. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J. Exp. Med. 189:1565-1572.
32. Mentink-Kane, M. M., et al. 2004. IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc. Natl. Acad. Sci. U. S. A. 101:586-590.
33. Moreira, A. P., et al. 2008. CCR5-dependent regulatory T cell migration mediates fungal survival and severe immunosuppression. J. Immunol. 180: 3049-3056.
34. Murphy, P. M., et al. 2000. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52:145-176.
35. Pellegrino, J., and D. G. Macedo. 1955. A simplified method for concentration of cercarial. J. Parasitol. 41:306-309.
36. Pellegrino, J., and A. F. Siqueira. 1956. A perfusion technic for recovery of Schistosoma mansoni from experimentally infected guinea pigs. Rev. Bras. Malariol. Doencas Trop. 8:589-597.
37. Ramalingam, T. R., et al. 2008. Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain. Nat. Immunol. 9:25-33.
38. Reddy, G. K., and C. S. Enwemeka. 1996. A simplified method for the analysis of hydroxyproline in biological tissues. Clin. Biochem. 29:225-229.
39. Samson, M., O. Labbe, C. Mollereau, G. Vassart, and M. Parmentier. 1996. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35:3362-3367.
40. Schuh, J. M., K. Blease, and C. M. Hogaboam. 2002. The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice. FASEB J. 16:228-230.
41. Souza, P. R., A. L. Souza, D. Negrão-Correa, A. L. Teixeira, and M. M. Teixeira. 2008. The role of chemokines in controlling granulomatous inflammation in Schistosoma mansoni infection. Acta Trop. 108:135-138.
42. Souza, A. L., et al. 2005. Potential role of the chemokine macrophage inflammatory protein 1-alpha in human and experimental schistosomiasis. Infect. Immun. 73:2515-2523.
43. Souza, A. L., S. R. Sousa-Pereira, M. M. Teixeira, J. R. Lambertucci, and A. L. Teixeira. 2006. The role of chemokines in Schistosoma mansoni infection: insights from human disease and murine models. Mem. Inst. Oswaldo Cruz 101:333-338.
44. Sozzani, S., et al. 1997. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J. Immunol. 159:1993-2000.
45. Strath, M., D. J. Warren, and C. J. Sanderson. 1985. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J. Immunol. Methods 83:209-215.
46. + regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J. Exp. Med. 203:2451-2460.
47. Zhou, Y., et al. 1998. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J. Immunol. 160:4018-4025.